CD81 is a receptor for equine arteritis virus (family: Arteriviridae).
- Journal Article
Summary
This study demonstrates that the equine arteritis virus (EAV), which belongs to the arterivirus family, uses an alternative receptor, CD81, to enter its host cells, unlike other arteriviruses commonly known to use the CD163 receptor.
Understanding the Research
The research aims to unravel the infection mechanism of horse arterivirus (Equine Arteritis Virus), which is distinct from other arteriviruses in terms of receptor utilization and increased tropism. Arteriviruses are a group of single-stranded RNA viruses known to infect a variety of animal hosts, primarily through the macrophage-specific molecule CD163 as a receptor. However, EAV diverges from this receptor utilization trend, prompting researchers to investigate alternative receptors.
- The researchers used a genome-wide CRISPR knockout screen to discover alternative receptors. This method led to the identification of CD81, a plasma membrane tetraspanin, as a critical host factor in EAV infection.
- Evidence was found that either genetic knockout of CD81, or its pre-incubation with a soluble form, could protect cells from EAV infection. However, this had no effect on susceptibility to other arteriviruses, indicating CD81’s specificity as an EAV receptor.
- To further implicate CD81 in the EAV entry process, an experiment was conducted in which the EAV genome was transfected into CD81-knockout cells. This process resulted in the creation of infectious EAV, asserting CD81’s role in EAV entry.
- Testing of CD81 orthologs from arterivirus hosts revealed that CD81 in some species, such as the brushtail possum, was incompatible with EAV entry. This suggests a biological barrier against cross-species EAV infection.
- The study also identified alpha helix “D”, located on the large extracellular loop of CD81, as vital for EAV entry. This was determined using horse/possum CD81 chimeras.
Significance of the Research
This study is of importance as it highlights the adaptability of arteriviruses, such as the equine arteritis virus, in choosing alternate host cell entry points. This is a significant finding for equine health, as it augments the understanding of how the EAV obtains entry into the host cell, a knowledge that may influence future treatment and prevention strategies. Additionally, it adds a fresh dimension to the understanding of arteriviruses, establishing that they can adopt new host molecules as receptors, which in turn impacts the types of cells they can infect, the diseases they induce, and their modes of transmission.
Cite This Article
Publication
Researcher Affiliations
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
- University of Wisconsin-Madison Cellular and Molecular Pathology Graduate Program, Madison, Wisconsin, USA.
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
- Stanford University School of Medicine, Stanford, California, USA.
- Structural Virology Section, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA.
- Structural Virology Section, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA.
- MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
- Molecular Virology Laboratory, Leiden University Center of Infectious Diseases (LUCID), Leiden University Medical Center, Leiden, South Holland, The Netherlands.
- Department of Biochemistry, Institute for Molecular Virology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
MeSH Terms
- Animals
- Equartevirus / physiology
- Equartevirus / genetics
- Receptors, Virus / metabolism
- Receptors, Virus / genetics
- Tetraspanin 28 / genetics
- Tetraspanin 28 / metabolism
- Horses
- Virus Internalization
- Arterivirus Infections / virology
- Arterivirus Infections / veterinary
- Humans
- Cell Line
- Viral Tropism
- Antigens, CD / metabolism
- Gene Knockout Techniques
- CD163 Antigen
Grant Funding
- P30 CA014520 / NCI NIH HHS
- R21 AI180295 / NIAID NIH HHS
- T32 GM135119 / NIGMS NIH HHS
- R21AI180295 / National Institute of Allergy and Infectious Diseases
Conflict of Interest Statement
References
- Kuhn JH, Lauck M, Bailey AL, Shchetinin AM, Vishnevskaya TV, Bào Y, Ng TFF, LeBreton M, Schneider BS, Gillis A. Reorganization and expansion of the nidoviral family arteriviridae. Arch Virol 161:755–768.
- Benfield DA, Nelson E, Collins JE, Harris L, Goyal SM, Robison D, Christianson WT, Morrison RB, Gorcyca D, Chladek D. Characterization of swine infertility and respiratory syndrome (SIRS) virus (isolate ATCC VR-2332). J Vet Diagn Invest 4:127–133.
- Jiang P, Chen PY, Dong YY, Cai JL, Cai BX, Jiang ZH. Isolation and genome characterization of porcine reproductive and respiratory syndrome virus in P.R. China. J Vet Diagn Invest 12:156–158.
- Wensvoort G, Terpstra C, Pol JM, ter Laak EA, Bloemraad M, de Kluyver EP, Kragten C, van Buiten L, den Besten A, Wagenaar F. Mystery swine disease in the Netherlands: the isolation of lelystad virus. Vet Q 13:121–130.
- van den Broek MF, Spörri R, Even C, Plagemann PG, Hänseler E, Hengartner H, Zinkernagel RM. Lactate dehydrogenase-elevating virus (LDV): lifelong coexistence of virus and LDV-specific immunity. J Immunol 159:1585–1588.
- Chirnside ED. Equine arteritis virus: an overview. Br Vet J 148:181–197.
- Brinton MA, Gulyaeva AA, Balasuriya UBR, Dunowska M, Faaberg KS, Goldberg T, Leung FCC, Nauwynck HJ, Snijder EJ, Stadejek T, Gorbalenya AE. ICTV virus taxonomy profile: arteriviridae 2021. J Gen Virol 102.
- Snijder EJ, Dobbe JC, Spaan WJM. Heterodimerization of the two major envelope proteins is essential for arterivirus infectivity. J Virol 77:97–104.
- de Vries AA, Post SM, Raamsman MJ, Horzinek MC, Rottier PJ. The two major envelope proteins of equine arteritis virus associate into disulfide-linked heterodimers. J Virol 69:4668–4674.
- Faaberg KS, Even C, Palmer GA, Plagemann PG. Disulfide bonds between two envelope proteins of lactate dehydrogenase-elevating virus are essential for viral infectivity. J Virol 69:613–617.
- Mardassi H, Massie B, Dea S. Intracellular synthesis, processing, and transport of proteins encoded by ORFs 5 to 7 of porcine reproductive and respiratory syndrome virus. Virology (Auckl) 221:98–112.
- Wieringa R, de Vries AAF, Rottier PJM. Formation of disulfide-linked complexes between the three minor envelope glycoproteins (GP2b, GP3, and GP4) of equine arteritis virus. J Virol 77:6216–6226.
- Tian D, Wei Z, Zevenhoven-Dobbe JC, Liu R, Tong G, Snijder EJ, Yuan S. Arterivirus minor envelope proteins are a major determinant of viral tropism in cell culture. J Virol 86:3701–3712.
- Duan X, Nauwynck HJ, Favoreel HW, Pensaert MB. Identification of a putative receptor for porcine reproductive and respiratory syndrome virus on porcine alveolar macrophages. J Virol 72:4520–4523.
- Calvert JG, Slade DE, Shields SL, Jolie R, Mannan RM, Ankenbauer RG, Welch S-KW. CD163 expression confers susceptibility to porcine reproductive and respiratory syndrome viruses. J Virol 81:7371–7379.
- Van Gorp H, Van Breedam W, Delputte PL, Nauwynck HJ. Sialoadhesin and CD163 join forces during entry of the porcine reproductive and respiratory syndrome virus. J Gen Virol 89:2943–2953.
- Yang H, Zhang J, Zhang X, Shi J, Pan Y, Zhou R, Li G, Li Z, Cai G, Wu Z. CD163 knockout pigs are fully resistant to highly pathogenic porcine reproductive and respiratory syndrome virus. Antiviral Res 151:63–70.
- Caì Y, Postnikova EN, Bernbaum JG, Yú S, Mazur S, Deiuliis NM, Radoshitzky SR, Lackemeyer MG, McCluskey A, Robinson PJ, Haucke V, Wahl-Jensen V, Bailey AL, Lauck M, Friedrich TC, O’Connor DH, Goldberg TL, Jahrling PB, Kuhn JH. Simian hemorrhagic fever virus cell entry is dependent on CD163 and uses a clathrin-mediated endocytosis-like pathway. J Virol 89:844–856.
- Warren CJ, Yu S, Peters DK, Barbachano-Guerrero A, Yang Q, Burris BL, Worwa G, Huang I-C, Wilkerson GK, Goldberg TL, Kuhn JH, Sawyer SL. Primate hemorrhagic fever-causing arteriviruses are poised for spillover to humans. Cell 185:3980–3991.
- Shaw TM, Maloney SM, Nennig K, Ramuta MD, Norton A, Ibarra R, Kuehnert P, Brinton M, Faaberg K, Kuhn JH, O’Connor DH, Warren CJ, Bailey AL. Ectopic expression of murine CD163 enables cell-culture isolation of lactate dehydrogenase-elevating virus 63 years after its discovery. J Virol 97:e0093023.
- Shaw TM, Huey D, Mousa-Makky M, Compaleo J, Nennig K, Shah AP, Jiang F, Qiu X, Klipsic D, Rowland RRR, Slukvin II, Sullender ME, Baldridge MT, Li H, Warren CJ, Bailey AL. The neonatal Fc receptor (FcRn) is a pan-arterivirus receptor. Nat Commun 15:6726.
- Vairo S, Favoreel H, Scagliarini A, Nauwynck H. Identification of target cells of a European equine arteritis virus strain in experimentally infected ponies. Vet Microbiol 167:235–241.
- Kalemera MD, Capella-Pujol J, Chumbe A, Underwood A, Bull RA, Schinkel J, Sliepen K, Grove J. Optimized cell systems for the investigation of hepatitis C virus E1E2 glycoproteins. J Gen Virol 102:jgv001512.
- van den Born E, Posthuma CC, Gultyaev AP, Snijder EJ. Discontinuous subgenomic RNA synthesis in arteriviruses is guided by an RNA hairpin structure located in the genomic leader region. J Virol 79:6312–6324.
- Cai Y, Yu S, Fang Y, Bollinger L, Li Y, Lauck M, Postnikova EN, Mazur S, Johnson RF, Finch CL, Radoshitzky SR, Palacios G, Friedrich TC, Goldberg TL, O’Connor DH, Jahrling PB, Kuhn JH. Development and characterization of a cDNA-launch recombinant simian hemorrhagic fever virus expressing enhanced green fluorescent protein: ORF 2b’ is not required for in vitro virus replication. Viruses 13:632.
- van den Born E, Posthuma CC, Knoops K, Snijder EJ. An infectious recombinant equine arteritis virus expressing green fluorescent protein from its replicase gene. J Gen Virol 88:1196–1205.
- Merzlyak EM, Goedhart J, Shcherbo D, Bulina ME, Shcheglov AS, Fradkov AF, Gaintzeva A, Lukyanov KA, Lukyanov S, Gadella TWJ, Chudakov DM. Bright monomeric red fluorescent protein with an extended fluorescence lifetime. Nat Methods 4:555–557.
- Li W, Xu H, Xiao T, Cong L, Love MI, Zhang F, Irizarry RA, Liu JS, Brown M, Liu XS. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens. Genome Biol 15:554.
- Wei J, Alfajaro MM, DeWeirdt PC, Hanna RE, Lu-Culligan WJ, Cai WL, Strine MS, Zhang S-M, Graziano VR, Schmitz CO. Genome-wide CRISPR screens reveal host factors critical for SARS-CoV-2 infection. Cell 184:76–91.
- Kowarz E, Löscher D, Marschalek R. Optimized sleeping beauty transposons rapidly generate stable transgenic cell lines. Biotechnol J 10:647–653.
- Kumar A, Hossain RA, Yost SA, Bu W, Wang Y, Dearborn AD, Grakoui A, Cohen JI, Marcotrigiano J. Structural insights into hepatitis C virus receptor binding and entry. Nature 598:521–525.
- Kumar A, Rohe TC, Elrod EJ, Khan AG, Dearborn AD, Kissinger R, Grakoui A, Marcotrigiano J. Regions of hepatitis C virus E2 required for membrane association. Nat Commun 14:433.
- Mirdita M, Schütze K, Moriwaki Y, Heo L, Ovchinnikov S, Steinegger M. ColabFold: making protein folding accessible to all. Nat Methods 19:679–682.
- Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, Tunyasuvunakool K, Bates R, Žídek A, Potapenko A. Highly accurate protein structure prediction with AlphaFold. Nature 596:583–589.
- Meng EC, Goddard TD, Pettersen EF, Couch GS, Pearson ZJ, Morris JH, Ferrin TE. UCSF ChimeraX: tools for structure building and analysis. Protein Sci 32:e4792.
- Varadi M, Anyango S, Deshpande M, Nair S, Natassia C, Yordanova G, Yuan D, Stroe O, Wood G, Laydon A. AlphaFold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res 50:D439–D444.
- Snijder EJ, Kikkert M, Fang Y. Arterivirus molecular biology and pathogenesis. J Gen Virol 94:2141–2163.
- Zhu X, Peng J, Raychowdhury R, Nakajima A, Lencer WI, Blumberg RS. The heavy chain of neonatal Fc receptor for IgG is sequestered in endoplasmic reticulum by forming oligomers in the absence of beta2-microglobulin association. Biochem J 367:703–714.
- Sarkar S, Chelvarajan L, Go YY, Cook F, Artiushin S, Mondal S, Anderson K, Eberth J, Timoney PJ, Kalbfleisch TS, Bailey E, Balasuriya UBR. Equine arteritis virus uses equine CXCL16 as an entry receptor. J Virol 90:3366–3384.
- Cunha ES, Sfriso P, Rojas AL, Roversi P, Hospital A, Orozco M, Abrescia NGA. Mechanism of structural tuning of the hepatitis C virus human cellular receptor CD81 large extracellular loop. Structure 25:53–65.
- Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S. Binding of hepatitis C virus to CD81. Science 282:938–941.
- Farquhar MJ, Hu K, Harris HJ, Davis C, Brimacombe CL, Fletcher SJ, Baumert TF, Rappoport JZ, Balfe P, McKeating JA. Hepatitis C virus induces CD81 and claudin-1 endocytosis. J Virol 86:4305–4316.
- Flint M, von Hahn T, Zhang J, Farquhar M, Jones CT, Balfe P, Rice CM, McKeating JA. Diverse CD81 proteins support hepatitis C virus infection. J Virol 80:11331–11342.
- Roccasecca R, Ansuini H, Vitelli A, Meola A, Scarselli E, Acali S, Pezzanera M, Ercole BB, McKeating J, Yagnik A, Lahm A, Tramontano A, Cortese R, Nicosia A. Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2. J Virol 77:1856–1867.
- Petracca R, Falugi F, Galli G, Norais N, Rosa D, Campagnoli S, Burgio V, Di Stasio E, Giardina B, Houghton M, Abrignani S, Grandi G. Structure-function analysis of hepatitis C virus envelope-CD81 binding. J Virol 74:4824–4830.
- Zhang J, Randall G, Higginbottom A, Monk P, Rice CM, McKeating JA. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J Virol 78:1448–1455.
- Cejas RB, Ferguson DC, Quiñones-Lombraña A, Bard JE, Blanco JG. Contribution of DNA methylation to the expression of FCGRT in human liver and myocardium. Sci Rep 9:8674.
- D’Hooghe L, Chalmers AD, Heywood S, Whitley P. Cell surface dynamics and cellular distribution of endogenous FcRn. PLOS ONE 12:e0182695.
- McCollum WH. Responses of horses vaccinated with avirulent modified-live equine arteritis virus propagated in the E. Derm (NBL-6) cell line to nasal inoculation with virulent virus. Am J Vet Res 47:1931–1934.
- Giles J, Perrott M, Roe W, Dunowska M. The aetiology of wobbly possum disease: reproduction of the disease with purified nidovirus. Virology (Auckl) 491:20–26.
- Giles J, Perrott M, Roe W, Shrestha K, Aberdein D, Morel P, Dunowska M. Viral RNA load and histological changes in tissues following experimental infection with an arterivirus of possums (wobbly possum disease virus). Virology (Auckl) 522:73–80.
- Guindon S, Dufayard J-F, Lefort V, Anisimova M, Hordijk W, Gascuel O. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol 59:307–321.
- Zimmerman B, Kelly B, McMillan BJ, Seegar TCM, Dror RO, Kruse AC, Blacklow SC. Crystal structure of a full-length human tetraspanin reveals a cholesterol-binding pocket. Cell 167:1041–1051.
- Honegger A, Plückthun A. Yet another numbering scheme for immunoglobulin variable domains: an automatic modeling and analysis tool. J Mol Biol 309:657–670.
- Veit M, Matczuk AK, Sinhadri BC, Krause E, Thaa B. Membrane proteins of arterivirus particles: structure, topology, processing and function. Virus Res 194:16–36.
- Morosky S, Wells AI, Lemon K, Evans AS, Schamus S, Bakkenist CJ, Coyne CB. The neonatal Fc receptor is a pan-echovirus receptor. Proc Natl Acad Sci USA 116:3758–3763.
- Zhao X, Zhang G, Liu S, Chen X, Peng R, Dai L, Qu X, Li S, Song H, Gao Z. Human neonatal Fc receptor is the cellular uncoating receptor for enterovirus B. Cell 177:1553–1565.
- Yang K, Dong J, Li J, Zhou R, Jia X, Sun Z, Zhang W, Li Z. The neonatal Fc receptor (FcRn) is required for porcine reproductive and respiratory syndrome virus uncoating. J Virol 99:e0121824.
- Scarselli E, Ansuini H, Cerino R, Roccasecca RM, Acali S, Filocamo G, Traboni C, Nicosia A, Cortese R, Vitelli A. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21:5017–5025.
- Cormier EG, Tsamis F, Kajumo F, Durso RJ, Gardner JP, Dragic T. CD81 is an entry coreceptor for hepatitis C virus. Proc Natl Acad Sci USA 101:7270–7274.
- Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, Wölk B, Hatziioannou T, McKeating JA, Bieniasz PD, Rice CM. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446:801–805.
- Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, de Jong YP, Rice CM. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457:882–886.
- Sharma NR, Mateu G, Dreux M, Grakoui A, Cosset F-L, Melikyan GB. Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion. J Biol Chem 286:30361–30376.
- Higginbottom A, Quinn ER, Kuo C-C, Flint M, Wilson LH, Bianchi E, Nicosia A, Monk PN, McKeating JA, Levy S. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. J Virol 74:3642–3649.
- Meola A, Sbardellati A, Bruni Ercole B, Cerretani M, Pezzanera M, Ceccacci A, Vitelli A, Levy S, Nicosia A, Traboni C, McKeating J, Scarselli E. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection. J Virol 74:5933–5938.
- Li F. Receptor recognition mechanisms of coronaviruses: a decade of structural studies. J Virol 89:1954–1964.
- Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol 5:562–569.
- Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 17:181–192.
- Wang Q, Noettger S, Xie Q, Pastorio C, Seidel A, Müller JA, Jung C, Jacob T, Sparrer KMJ, Zech F, Kirchhoff F. Determinants of species-specific utilization of ACE2 by human and animal coronaviruses. Commun Biol 6:1051.
- Xiong Q, Cao L, Ma C, Tortorici MA, Liu C, Si J, Liu P, Gu M, Walls AC, Wang C, Shi L, Tong F, Huang M, Li J, Zhao C, Shen C, Chen Y, Zhao H, Lan K, Corti D, Veesler D, Wang X, Yan H. Close relatives of MERS-CoV in bats use ACE2 as their functional receptors. Nature 612:748–757.
- Lee J, Zepeda SK, Park Y-J, Taylor AL, Quispe J, Stewart C, Leaf EM, Treichel C, Corti D, King NP, Starr TN, Veesler D. Broad receptor tropism and immunogenicity of a clade 3 sarbecovirus. Cell Host & Microbe 31:1961–1973.
- Duan X, Nauwynck HJ, Pensaert MB. Effects of origin and state of differentiation and activation of monocytes/macrophages on their susceptibility to porcine reproductive and respiratory syndrome virus (PRRSV). Arch Virol 142:2483–2497.
- Stueckemann JA, Ritzi DM, Holth M, Smith MS, Swart WJ, Cafruny WA, Plagemann PGW. Replication of lactate dehydrogenase-elevating virus in macrophages. J Gen Virol 59:245–262.
- Meulenberg JJ, Hulst MM, de Meijer EJ, Moonen PL, den Besten A, de Kluyver EP, Wensvoort G, Moormann RJ. Lelystad virus, the causative agent of porcine epidemic abortion and respiratory syndrome (PEARS), is related to LDV and EAV. Virology (Auckl) 192:62–72.
- Carossino M, Loynachan AT, Canisso IF, Cook RF, Campos JR, Nam B, Go YY, Squires EL, Troedsson MHT, Swerczek T, Del Piero F, Bailey E, Timoney PJ, Balasuriya UBR. Equine arteritis virus has specific tropism for stromal cells and CD8+ T and CD21+ B lymphocytes but not for glandular epithelium at the primary site of persistent infection in the stallion reproductive tract. J Virol 91:00418–17.
- Luo RF, Zhao S, Tibshirani R, Myklebust JH, Sanyal M, Fernandez R, Gratzinger D, Marinelli RJ, Lu ZS, Wong A, Levy R, Levy S, Natkunam Y. CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas. Hum Pathol 41:271–280.
- Rohlena J, Volger OL, van Buul JD, Hekking LHP, van Gils JM, Bonta PI, Fontijn RD, Post JA, Hordijk PL, Horrevoets AJG. Endothelial CD81 is a marker of early human atherosclerotic plaques and facilitates monocyte adhesion. Cardiovasc Res 81:187–196.
- BRYANS JT, DOLL ER, JONES TC. The lesions of equine viral arteritis. Cornell Vet 47:52–68.
- Timoney PJ, McCollum WH. Equine viral arteritis. Vet Clin North Am Equine Pract 9:295–309.
- Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C, Sjöstedt E, Asplund A. Proteomics. Tissue-based map of the human proteome. Science 347:1260419.
- Jankovičová J, Sečová P, Horovská Ľ, Olexiková L, Dujíčková L, Makarevich AV, Michalková K, Antalíková J. Distribution of tetraspanins in bovine ovarian tissue and fresh/vitrified oocytes. Histochem Cell Biol 159:163–183.
- Schoggins JW, MacDuff DA, Imanaka N, Gainey MD, Shrestha B, Eitson JL, Mar KB, Richardson RB, Ratushny AV, Litvak V, Dabelic R, Manicassamy B, Aitchison JD, Aderem A, Elliott RM, García-Sastre A, Racaniello V, Snijder EJ, Yokoyama WM, Diamond MS, Virgin HW, Rice CM. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505:691–695.